Order Article Reprints

Bowcock S, Atkin C, Iqbal G, Pratt G, Yong K, Neal RD, Planche T, Karunanithi K, Jenkins S, Stern S, et al. Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial. Cancers. 2023; 15(13):3337. https://doi.org/10.3390/cancers15133337

Bowcock, Stella, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D. Neal, Tim Planche, Kamaraj Karunanithi, Stephen Jenkins, Simon Stern, and et al. 2023. "Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial" Cancers 15, no. 13: 3337. https://doi.org/10.3390/cancers15133337

Bowcock, S., Atkin, C., Iqbal, G., Pratt, G., Yong, K., Neal, R. D., Planche, T., Karunanithi, K., Jenkins, S., Stern, S., Arnott, S., Toth, P., Wandroo, F., Dunn, J., & Drayson, M. T., on behalf of the TEAMM Trial Management Group and Trial Investigators. (2023). Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial. Cancers, 15(13), 3337. https://doi.org/10.3390/cancers15133337